1005 related articles for article (PubMed ID: 35751396)
41. Pharmacokinetics and Efficacy of a Potential Smallpox Therapeutic, Brincidofovir, in a Lethal Monkeypox Virus Animal Model.
Hutson CL; Kondas AV; Mauldin MR; Doty JB; Grossi IM; Morgan CN; Ostergaard SD; Hughes CM; Nakazawa Y; Kling C; Martin BE; Ellison JA; Carroll DS; Gallardo-Romero NF; Olson VA
mSphere; 2021 Feb; 6(1):. PubMed ID: 33536322
[TBL] [Abstract][Full Text] [Related]
42. A comprehensive review of monkeypox virus and mpox characteristics.
Alakunle E; Kolawole D; Diaz-Cánova D; Alele F; Adegboye O; Moens U; Okeke MI
Front Cell Infect Microbiol; 2024; 14():1360586. PubMed ID: 38510963
[TBL] [Abstract][Full Text] [Related]
43. Monkeypox virus: emerging of an old neglected virus.
Leclercq I
Virologie (Montrouge); 2023 Feb; 27(1):1-11. PubMed ID: 36896769
[TBL] [Abstract][Full Text] [Related]
44. [Monkeypox virus: emerging of an old neglected virus].
Leclercq I
Virologie (Montrouge); 2023 Feb; 27(1):11-21. PubMed ID: 36891776
[TBL] [Abstract][Full Text] [Related]
45. Recent advances in the diagnosis monkeypox: implications for public health.
McCarthy MW
Expert Rev Mol Diagn; 2022 Jul; 22(7):739-744. PubMed ID: 35997157
[TBL] [Abstract][Full Text] [Related]
46. The changing epidemiology of human monkeypox-A potential threat? A systematic review.
Bunge EM; Hoet B; Chen L; Lienert F; Weidenthaler H; Baer LR; Steffen R
PLoS Negl Trop Dis; 2022 Feb; 16(2):e0010141. PubMed ID: 35148313
[TBL] [Abstract][Full Text] [Related]
47. Atypical and Unique Transmission of Monkeypox Virus during the 2022 Outbreak: An Overview of the Current State of Knowledge.
Riopelle JC; Munster VJ; Port JR
Viruses; 2022 Sep; 14(9):. PubMed ID: 36146818
[TBL] [Abstract][Full Text] [Related]
48. [Perspectives on recent monkeypox outbreak in non-endemic areas].
Li XD; Cao W; Li TS
Zhonghua Yi Xue Za Zhi; 2022 Jul; 102(28):2148-2152. PubMed ID: 35872578
[TBL] [Abstract][Full Text] [Related]
49. Increased outbreaks of monkeypox highlight gaps in actual disease burden in Sub-Saharan Africa and in animal reservoirs.
Haider N; Guitian J; Simons D; Asogun D; Ansumana R; Honeyborne I; Velavan TP; Ntoumi F; Valdoleiros SR; Petersen E; Kock R; Zumla A
Int J Infect Dis; 2022 Sep; 122():107-111. PubMed ID: 35640830
[TBL] [Abstract][Full Text] [Related]
50. Monkeypox Outbreak 2022, from a Rare Disease to Global Health Emergence: Implications for Travellers.
Adegboye O; Alele F; Pak A; Alakunle E; Emeto T; Leggat P; Okeke M
Adv Exp Med Biol; 2024; 1451():355-368. PubMed ID: 38801590
[TBL] [Abstract][Full Text] [Related]
51. Outbreaks of human monkeypox after cessation of smallpox vaccination.
Reynolds MG; Damon IK
Trends Microbiol; 2012 Feb; 20(2):80-7. PubMed ID: 22239910
[TBL] [Abstract][Full Text] [Related]
52. Antiviral treatment is more effective than smallpox vaccination upon lethal monkeypox virus infection.
Stittelaar KJ; Neyts J; Naesens L; van Amerongen G; van Lavieren RF; Holý A; De Clercq E; Niesters HG; Fries E; Maas C; Mulder PG; van der Zeijst BA; Osterhaus AD
Nature; 2006 Feb; 439(7077):745-8. PubMed ID: 16341204
[TBL] [Abstract][Full Text] [Related]
53. Monkeypox disease transmission in an experimental setting: prairie dog animal model.
Hutson CL; Carroll DS; Gallardo-Romero N; Weiss S; Clemmons C; Hughes CM; Salzer JS; Olson VA; Abel J; Karem KL; Damon IK
PLoS One; 2011; 6(12):e28295. PubMed ID: 22164263
[TBL] [Abstract][Full Text] [Related]
54. Co-administration of tecovirimat and ACAM2000™ in non-human primates: Effect of tecovirimat treatment on ACAM2000 immunogenicity and efficacy versus lethal monkeypox virus challenge.
Russo AT; Berhanu A; Bigger CB; Prigge J; Silvera PM; Grosenbach DW; Hruby D
Vaccine; 2020 Jan; 38(3):644-654. PubMed ID: 31677948
[TBL] [Abstract][Full Text] [Related]
55. Phylogenomic analysis of the monkeypox virus (MPXV) 2022 outbreak: Emergence of a novel viral lineage?
Luna N; Ramírez AL; Muñoz M; Ballesteros N; Patiño LH; Castañeda SA; Bonilla-Aldana DK; Paniz-Mondolfi A; Ramírez JD
Travel Med Infect Dis; 2022; 49():102402. PubMed ID: 35840078
[TBL] [Abstract][Full Text] [Related]
56. Monkeypox (Mpox) outbreak during COVID-19 pandemic-Past and the future.
Aden D; Zaheer S; Kumar R; Ranga S
J Med Virol; 2023 Apr; 95(4):e28701. PubMed ID: 36951352
[TBL] [Abstract][Full Text] [Related]
57. Monkeypox - Enhancing public health preparedness for an emerging lethal human zoonotic epidemic threat in the wake of the smallpox post-eradication era.
Petersen E; Abubakar I; Ihekweazu C; Heymann D; Ntoumi F; Blumberg L; Asogun D; Mukonka V; Lule SA; Bates M; Honeyborne I; Mfinanga S; Mwaba P; Dar O; Vairo F; Mukhtar M; Kock R; McHugh TD; Ippolito G; Zumla A
Int J Infect Dis; 2019 Jan; 78():78-84. PubMed ID: 30453097
[TBL] [Abstract][Full Text] [Related]
58. Understanding the biology of monkeypox virus to prevent future outbreaks.
Moss B
Nat Microbiol; 2024 Jun; 9(6):1408-1416. PubMed ID: 38724757
[TBL] [Abstract][Full Text] [Related]
59. A brief on new waves of monkeypox and vaccines and antiviral drugs for monkeypox.
Hung YP; Lee CC; Lee JC; Chiu CW; Hsueh PR; Ko WC
J Microbiol Immunol Infect; 2022 Oct; 55(5):795-802. PubMed ID: 36115792
[TBL] [Abstract][Full Text] [Related]
60. National Monkeypox Surveillance, Central African Republic, 2001-2021.
Besombes C; Mbrenga F; Schaeffer L; Malaka C; Gonofio E; Landier J; Vickos U; Konamna X; Selekon B; Dankpea JN; Von Platen C; Houndjahoue FG; Ouaïmon DS; Hassanin A; Berthet N; Manuguerra JC; Gessain A; Fontanet A; Nakouné-Yandoko E
Emerg Infect Dis; 2022 Dec; 28(12):2435-2445. PubMed ID: 36328951
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
